4[1]Katz AM. Metabolism of the failing heart[J]. Cardioscience, 1993,4(4):199-203.
5[2]Neubauer S, Krahe T, Schindler R, et al. 31P magneticl resonamce spectroscopy in dilated cardiomyopathy and coronary artery disease: alteredcardiac high-energy phosphate metabolism in heart failure [J].Circulation, 1992, 86:1810-8.
6[3]Weiss RG, Bottomley PA, Hardy CJ. Regional myocardial metabolism ofhigh energy phosphates during isometric exercise in patients withcoromary ertery disease[J]. N Engl J Med, 1990, 323(23):1593-600.
7[4]Andreev NA, Andreeva TN, Bichkov IV. Effect of phosphocreatine incongestive heart failure [ J ]. Curr Ther Res 1992, 51 (5): 694-660.
8[5]Ferraro S, Codella C, Palumbo F, et al. Hemodynamic effects of creatinephosphate in patients with congetive heart failure: A double-blindcomparison trial versus placebo[J]. Clin Cardiol, 1996, 19: 699-703.
9Haller M. Evaluation of a new continuous thermodilution cardiac output monitor in critically ill patients: a prospective criterion standard study. Cri Care Med, 1995,23:860-866.
10Ye Y, Gong G, Ochiai K, et al. High-energy phosphate metabolism and creatine kinase in failing hearts: a new porcine model. Circulation , 2001, 103:1570-1576.
